• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.

作者信息

Szabo Agoston Gyula, Klausen Tobias Wirenfeldt, Abildgaard Niels, Gregersen Henrik, Silkjær Trine, Pedersen Per Trøllund, Pedersen Robert Schou, Helleberg Carsten, Hermansen Emil, Schnack Brian Iversen, Vangsted Annette Juul

机构信息

Department of Hematology Vejle Hospital, Vejle, Denmark.

Department of Hematology Herlev University Hospital, Herlev, Denmark.

出版信息

Blood Cancer J. 2021 Apr 7;11(4):70. doi: 10.1038/s41408-021-00460-0.

DOI:10.1038/s41408-021-00460-0
PMID:33828079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8027460/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca2/8027460/87519d4e2f94/41408_2021_460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca2/8027460/87519d4e2f94/41408_2021_460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca2/8027460/87519d4e2f94/41408_2021_460_Fig1_HTML.jpg

相似文献

1
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.M蛋白水平低且血红蛋白、肌酐、钙及血清游离轻链比值正常的多发性骨髓瘤的发病率及临床特征
Blood Cancer J. 2021 Apr 7;11(4):70. doi: 10.1038/s41408-021-00460-0.
2
Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.单克隆丙种球蛋白病中 M 蛋白、游离轻链和免疫球蛋白的参考变化值。
Clin Biochem. 2019 Dec;74:42-46. doi: 10.1016/j.clinbiochem.2019.09.004. Epub 2019 Sep 14.
3
Urine immunofixation electrophoresis and serum free light chain analyses benefit diagnosis of multiple myeloma in orthopedic patients with normal serum total proteins, creatinine, calcium, and hemoglobin.尿液免疫固定电泳和血清游离轻链分析有助于诊断血清总蛋白、肌酐、钙和血红蛋白正常的骨科患者多发性骨髓瘤。
Lab Med. 2024 Jul 3;55(4):454-459. doi: 10.1093/labmed/lmad104.
4
Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.血清重链/轻链对在意义未明的单克隆丙种球蛋白病和冒烟型骨髓瘤患者中的预后影响：来自单一机构的长期结果
Clin Lymphoma Myeloma Leuk. 2016 Jun;16(6):e71-7. doi: 10.1016/j.clml.2016.02.034. Epub 2016 Feb 27.
5
Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma.受累游离轻链和单克隆峰作为从意义未明的单克隆丙种球蛋白病进展为多发性骨髓瘤的标志物的比较评估。
Am J Hematol. 2021 Jan;96(1):23-30. doi: 10.1002/ajh.25999. Epub 2020 Sep 29.
6
[Biochemical and immunological findings of multiple myeloma].[多发性骨髓瘤的生化和免疫学研究结果]
Nihon Rinsho. 2007 Dec;65(12):2256-60.
7
Diagnostic performances of M-protein tests according to the clinical presentations of kidney disease.根据肾脏疾病临床表现的M蛋白检测诊断性能
Eur J Intern Med. 2016 Sep;33:88-92. doi: 10.1016/j.ejim.2016.06.028. Epub 2016 Jul 12.
8
A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.免疫球蛋白定量与浆细胞疾病的窗口：由免疫球蛋白重链和轻链连接处定义的抗原表位
Leukemia. 2013 Jan;27(1):1-2. doi: 10.1038/leu.2012.201.
9
[Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].血清游离轻链免疫测定在单克隆丙种球蛋白病诊断及随访中的应用价值
Rev Med Interne. 2007 Oct;28(10):689-97. doi: 10.1016/j.revmed.2007.04.010. Epub 2007 May 25.
10
Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.新型免疫球蛋白衍生生物标志物在诊断和随访球蛋白异常血症患者中的益处。
Ann Biol Clin (Paris). 2016 Oct 1;74(5):597-605. doi: 10.1684/abc.2016.1180.

引用本文的文献

1
A Novel Serum-Based Bioassay for Quantification of Cancer-Associated Transformation Activity: A Case-Control and Animal Study.一种用于定量癌症相关转化活性的新型血清生物测定法：病例对照研究和动物研究
Diagnostics (Basel). 2025 Aug 6;15(15):1975. doi: 10.3390/diagnostics15151975.
2
Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma.在临床环境中前行：多发性骨髓瘤诊断和预后生物标志物的最新进展。
Mol Biol Rep. 2024 Sep 9;51(1):972. doi: 10.1007/s11033-024-09892-w.

本文引用的文献

1
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?骨髓活检在浆细胞疾病患者中的作用：所有单克隆蛋白患者都需要进行活检吗？
Blood Cancer J. 2020 May 6;10(5):52. doi: 10.1038/s41408-020-0319-0.
2
Myeloma bone disease: from biology findings to treatment approaches.多发性骨髓瘤骨病：从生物学发现到治疗方法。
Blood. 2019 Apr 4;133(14):1534-1539. doi: 10.1182/blood-2018-11-852459. Epub 2019 Feb 13.
3
Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark.
多发性骨髓瘤血流感染的危险因素：丹麦 1154 例患者的基于人群研究。
Eur J Haematol. 2018 Jul;101(1):21-27. doi: 10.1111/ejh.13066. Epub 2018 May 4.
4
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.意义未明的单克隆丙种球蛋白病的长期随访
N Engl J Med. 2018 Jan 18;378(3):241-249. doi: 10.1056/NEJMoa1709974.
5
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.合并症对多发性骨髓瘤死亡率的影响：一项基于丹麦全国人口的研究。
Cancer Med. 2017 Jul;6(7):1807-1816. doi: 10.1002/cam4.1128. Epub 2017 Jun 22.
6
The Danish National Multiple Myeloma Registry.丹麦国家多发性骨髓瘤登记处。
Clin Epidemiol. 2016 Oct 25;8:583-587. doi: 10.2147/CLEP.S99463. eCollection 2016.
7
A population-based study of the impact of dialysis on mortality in multiple myeloma.一项基于人群的关于透析对多发性骨髓瘤死亡率影响的研究。
Br J Haematol. 2018 Feb;180(4):588-591. doi: 10.1111/bjh.14394. Epub 2016 Oct 21.
8
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.来那度胺联合地塞米松与观察治疗高危冒烟型多发性骨髓瘤患者（QuiRedex）：一项随机、对照、3 期临床试验的长期随访。
Lancet Oncol. 2016 Aug;17(8):1127-1136. doi: 10.1016/S1470-2045(16)30124-3. Epub 2016 Jul 9.
9
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.多发性骨髓瘤的更新诊断标准和分期系统。
Am Soc Clin Oncol Educ Book. 2016;35:e418-23. doi: 10.1200/EDBK_159009.
10
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.不符合接受造血干细胞支持下大剂量治疗条件的多发性骨髓瘤患者的早期死亡原因：一项基于丹麦全国骨髓瘤数据库的研究
Am J Hematol. 2015 Apr;90(4):E73-4. doi: 10.1002/ajh.23932. Epub 2015 Feb 2.